Template Description
3fqh: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHA 2-SUBSTITUTED 7-AZAINDOLE Solved by: X-RAY, Resolution: 2.26A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
697-990
3fqhA
32%
743-990
3fqhB
36%
>target
------------------------------ETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>3fqhB
VYLDRKLLTLEDKELGSTVKKGYYQMKKVVKTVAVKILK----PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENYY-------KAKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
4dfn: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHADAMANTYLPYRAZINE INHIBITOR Solved by: X-RAY, Resolution: 2.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
4dfnA
32%
>target
--ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----
>4dfnA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV-------------------------VKTVAVKILK----PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
3fqe: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHYM193306 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
3fqeA
32%
>target
--ISPNDVFITQ-VIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------
>3fqeA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV-------------------------VKTVAVKILK----PALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY----YKA--QKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
3emg: DISCOVERY AND SAR OF NOVEL 4-THIAZOLYL-2- PHENYLAMINOPYRIMIDINES AS POTENT INHIBITORS OF SPLEEN TYROSINE KINASE (SYK) Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-987
3emgA
32%
>target
ISPNDVFITQ-VIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKY--
>3emgA
LDRKLLTLEDKELGSGNFGTVKKGYYQMK--------------------------VVKTVAVKILK------LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY----YK---AKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY
[Model]
4fl1: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 1.79A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
4fl1A
31%
>target
--ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---
>4fl1A
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV-------------------------VKTVAVKILK----PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
1xbb: CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH GLEEVEC Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
1xbbA
31%
>target
--ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------
>1xbbA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKP----ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----K--AKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
4f4p: SYK IN COMPLEX WITH LIGAND LASW836 Solved by: X-RAY, Resolution: 2.37A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
4f4pA
31%
>target
ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-----
>4f4pA
LDRKLLTLEDKELGSGNFGTVKKGYVK-------------------------------TVAVKILKP----ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG
[Model]
3vf8: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC PYRAZOLYLBENZIMIDAZOLE INHIBITOR 416 Solved by: X-RAY, Resolution: 2.08A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-990
3vf8A
31%
>target
-DISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---
>3vf8A
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMVV---------------------------KTVAVKILP-----ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
4fl2: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 2.19A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
684-990
4fl2A
31%
>target
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------TFDISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---
>4fl2A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKIGTQREALPMDTEVYESPYADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3fqs: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHR406 Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
3fqsA
31%
>target
--ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------
>3fqsA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKP----ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----K--AKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGHH
[Model]
1xbc: CRYSTAL STRUCTURE OF THE SYK TYROSINE KINASE DOMAIN WITH STAUROSPORIN Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
1xbcA
31%
>target
--ISPNDVFITQ-VIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----
>1xbcA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV-------------------------VKTVAVKILP-----ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
3vf9: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE SYK CATALYTIC THIENOPYRAZOLYLINDOLE INHIBITOR 027 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
3vf9A
31%
>target
-ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---
>3vf9A
YLDRKLLTLEDKELGSGNFGTVKKGYQMKVV---------------------------KTVAVKILPA-----LKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3srv: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE (SYK) IN COMPLDIAMINOPYRIMIDINE CARBOXAMIDE INHIBITOR Solved by: X-RAY, Resolution: 1.95A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
3srvA
32%
>target
-ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--
>3srvA
YLDRKLLTL-EDKELGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKA-----LKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENYY---KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV
[Model]
687-988
3srvB
31%
>target
-ISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYI--
>3srvB
YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKV-------------------------VKTVAVKILP-----ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD
[Model]
4fl3: STRUCTURAL AND BIOPHYSICAL CHARACTERIZATION OF THE SYK ACTSWITCH Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
4fl3A
31%
>target
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------FDISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL----
>4fl3A
SANHLPFFFGNITREEAEDYLVQGGMSDGLYLLRQSRNYLGGFALSVAHGRKAHHYTIERELNGTYAIAGGRTHASPADLCHYHSQESDGLVCLLKKPFNRPQGVQPKTGPFEDLKENLIREYVKQTWNLQGQALEQAIISQKPQLEKLIATTAHEKMPWFHGKISREESEQIVLIGSKTNGKFLIRARDNNGSYALCLLHEGKVLHYRIDKDKTGKLSIPEGKKFDTLWQLVEHYSYKADGLLRVLTVPCQKREALPMDTEVFESPFADPEEIRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKAL----------------RAPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVN
[Model]
3mj2: X-RAY CRYSTAL STRUCTURE OF ITK COMPLEXED WITH INHIBITOR BM Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-987
3mj2A
31%
>target
-ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKY
>3mj2A
VIDPSELTFVQEIGSGQFGLVHLGYWLNK----------------------------DKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEASVIH-----RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS-----STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAAI
[Model]
1xba: CRYSTAL STRUCTURE OF APO SYK TYROSINE KINASE DOMAIN Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
1xbaA
31%
>target
--ISPNDVFITQ-VIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----
>1xbaA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMVV---------------------------KTVAVKILP-----ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
4hct: CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 52 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
4hctA
30%
>target
--FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>4hctA
GKWVIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
3tub: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-(5-(6,7- DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-3-((1R,2S)-2- PHENYLCYCLOPROPYL)UREA Solved by: X-RAY, Resolution: 2.23A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-990
3tubA
30%
>target
--DISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>3tubA
EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLP----------------------VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
4hcu: CRYSTAL STRUCTURE OF ITK IN COMPLEXT WITH COMPOUND 40 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
4hcuA
30%
>target
FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>4hcuA
WVIDPSELTFVQEIGSGQFGLVHLGYWLNK----------------------------DKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
4dfl: CRYSTAL STRUCTURE OF SPLEEN TYROSINE KINASE COMPLEXED WITHSULFONAMIDOPYRAZINE PIPERIDINE INHIBITOR Solved by: X-RAY, Resolution: 1.98A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-990
4dflA
30%
>target
--ISPNDVFI-TQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----
>4dflA
VYLDRKLLTLEDKELGSGTVKKGYYQMV------------------------------VKTVAVKILP-----ALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNE
[Model]
3qgw: CRYSTAL STRUCTURE OF ITK KINASE BOUND TO AN INHIBITOR Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
3qgwA
30%
>target
ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>3qgwA
IDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIKEGSM--SEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGFP----------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES
[Model]
3t9t: CRYSTAL STRUCTURE OF BTK MUTANT (F435T,K596R) COMPLEXED WIIMIDAZO[1,5-A]QUINOXALINE Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
3t9tA
30%
>target
FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>3t9tA
WVIDPSELTFVQEIGSGQFGLVHLGYWLNK----------------------------DKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
3tuc: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH 1-BENZYL-N-(5-DIMETHOXYQUINOLIN-4-YLOXY)PYRIDIN-2-YL)-2-OXO-1,2-DIHYDROCARBOXAMIDE Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-990
3tucA
30%
>target
-----FDISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>3tucA
IRPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGLP----------------------VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV
[Model]
4hcv: CRYSTAL STRUCTURE OF ITK IN COMPLEX WITH COMPOUND 53 Solved by: X-RAY, Resolution: 1.48A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
4hcvA
30%
>target
FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>4hcvA
WVIDPSELTFVQEIGSGQFGLVHLGYWLNK----------------------------DKVAIKTIREGAMS--EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-----TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES
[Model]
3qgy: CRYSTAL STRUCTURE OF ITK INHIBITOR COMPLEX Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
3qgyA
30%
>target
---ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>3qgyA
HMVIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIKEGSM--SEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPV-----------------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES
[Model]
687-987
3qgyB
30%
>target
--ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKY-
>3qgyB
MVIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIKEGS--MSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTP---------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA
[Model]
3tud: CRYSTAL STRUCTURE OF SYK KINASE DOMAIN WITH N-(4-METHYL-3-OXO-2-(PHENYLAMINO)-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-6-Y(TRIFLUOROMETHYL)BENZAMIDE Solved by: X-RAY, Resolution: 2.33A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-990
3tudA
30%
>target
-DISPNDVFIT-QVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----
>3tudA
VYLDRKLLTLEDKELGSGNFGTVKKGYYQMKK-------------------------VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEESNFVH-----RDLAARNVLLVTQHYAKISDFGKW---------------------PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNH
[Model]
1snx: CRYSTAL STRUCTURE OF APO INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 3.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
1snxA
29%
>target
-ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL--
>1snxA
VIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPV-----------------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
687-989
1snxB
29%
>target
-ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL--
>1snxB
VIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPV-----------------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
1sm2: CRYSTAL STRUCTURE OF THE PHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
1sm2A
29%
>target
-ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL--
>1sm2A
VIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPV-----------------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
687-988
1sm2B
29%
>target
ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYI-
>1sm2B
IDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFPVK------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE
[Model]
1snu: CRYSTAL STRUCTURE OF THE UNPHOSPHORYLATED INTERLEUKIN-2 TYROSINE KINASE CATALYTIC DOMAIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
1snuA
29%
>target
-ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL--
>1snuA
VIDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPV-----------------------KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
687-988
1snuB
29%
>target
ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYI-
>1snuB
IDPSELTFVQEIGSGQFGLVHLGYWLN----------------------------KDKVAIKTIREGA--MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFPVK------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE
[Model]
3v8t: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 477 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
3v8tB
29%
>target
-FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL--
>3v8tB
GSVIDPSELTFVQEIGSG--GLVHLGYWLN----------------------------KDKVAIKTIAMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTP---------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3v8w: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 469 Solved by: X-RAY, Resolution: 2.27A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
3v8wA
28%
>target
-FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL--
>3v8wA
GSVIDPSELTFVQEIGSG--GLVHLGYWLN----------------------------KDKVAIKTIRGAM---SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPVK-----------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYER-SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
685-990
3v8wB
28%
>target
-FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>3v8wB
GSVIDPSELTFVQEIGSG--GLVHLGYWLN----------------------------KDKVAIKTIRMS-----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGPVK-----------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3v5j: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 090 Solved by: X-RAY, Resolution: 2.59A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-990
3v5jB
28%
>target
-FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--
>3v5jB
GSVIDPSELTFVQEIGSG--GLVHLGYWLN----------------------------KDKVAIKTIMS------EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFPVK------------------------WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESGL
[Model]
3v5l: CRYSTAL STRUCTURE OF INTERLEUKIN-2 INDUCIBLE T-CELL KINASECATALYTIC DOMAIN WITH THIENOPYRAZOLYLINDOLE INHIBITOR 542 Solved by: X-RAY, Resolution: 1.86A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-987
3v5lC
28%
>target
--DISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKY-
>3v5lC
GSVIDPSELT---FVQEIGSGLVHLGYWLN----------------------------KDKVAIKTIREGAM--SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMTF--------------------PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIA
[Model]
686-990
3v5lD
29%
>target
--DISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>3v5lD
GSVIDPSELTFVQEIGSG-QGLVHLGYWLN----------------------------KDKVAIKTIRAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG---LFAAETLLGMCLDVCEGMAYLEEACVIH-----RDLAARNCLVGENQVIKVSDFGMFP---------------------VKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG
[Model]
3ppz: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN IN COMPLEX WITH ST Solved by: X-RAY, Resolution: 2.99A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
685-989
3ppzA
28%
>target
----FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMG--YVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVM-IGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL
>3ppzA
DGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-----------------------------SDVAVKILME---AERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVH-----RDLKSPNLLVDKKYTVKVCDFGLSRLKASTFL------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
685-989
3ppzB
27%
>target
----FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMG--YVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEV-MIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL
>3ppzB
DGDDMDIPWCDLNIKEKIG----ATVHRAEWHG-----------------------------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPIVH-----RDLKSPNLLVDKKYTVKVCDFGLSRLKASTFL------SSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
3lxp: STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 Solved by: X-RAY, Resolution: 1.65A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
3lxpA
27%
>target
----ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA--EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWD---------------WTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL----
>3lxpA
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN-------------------------TGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQHYIH-----RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG
[Model]
3lxn: STRUCTURAL AND THERMODYNAMIC CHARACTERIZATION OF THE TYK2 KINASE DOMAINS IN COMPLEX WITH CP-690550 AND CMP-6 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
3lxnA
27%
>target
----ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAE--PVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWD---------------WTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL----
>3lxnA
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTND-----------------------GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQHYIH-----RDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY------RVGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG
[Model]
4e20: STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE IN Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-989
4e20A
27%
>target
---DISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSF---GERPYWDWTNQ-------KVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL---
>4e20A
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTND-----------------------GTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCE--DSVQLVMEYVPLGSLRDYLPRH-----CVGLAQLLLFAQQICEGMAYLHAQHYIH-----RALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ
[Model]
4e1z: STRUCTURE OF MOUSE TYK-2 COMPLEXED TO A 3-AMINOINDAZOLE IN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-989
4e1zA
27%
>target
----DISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSF---GERPYWDWTN-----------QKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL---
>4e1zA
SDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTND-----------------------GTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCED-KSVQLVMEYVPLGSLRDYLPRH-----CVGLAQLLLFAQQICEGMAYLHAQHYIH-----RALAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ
[Model]
3nz0: NON-PHOSPHORYLATED TYK2 KINASE WITH CMP6 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
687-989
3nz0A
26%
>target
----ISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA--EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWT-----NQ----KVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL----
>3nz0A
DPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTND-----------------------GTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQHYIH-----RNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRH
[Model]
3p86: CRYSTAL STRUCTURE OF CTR1 KINASE DOMAIN MUTANT D676N IN COSTAUROSPORINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-989
3p86A
26%
>target
-DISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMG--YVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEV-MIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL
>3p86A
MDIPWCDLNIKEKIGAGSFGTVHRAEWHG-----------------------------SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA-REQLDERRRLSMAYDVAKGMNYLHNRNPPIVH-----RNLKSPNLLVDKKYTVKVCDFGTP-----------------------EWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
685-989
3p86B
26%
>target
-FDISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMG--YVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVM-IGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL
>3p86B
DMDIPWCDLNIKEKIGAGSFGTVHRAEWHG-----------------------------SDVAVKIL-----------FLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPIVH-----RNLKSPNLLVDKKYTVKVCDFGTP-----------------------EWMAPEVLRDEPSNEKSDVYSFGVILWELAT-LQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK
[Model]
3nyx: NON-PHOSPHORYLATED TYK2 JH1 DOMAIN WITH QUINOLINE-THIADIAZTHIOPHENE INHIBITOR Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
686-989
3nyxA
26%
>target
--DISPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA-EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDW---------------TNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL----
>3nyxA
PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTN-------------------------DGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQEKSLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHSQHYIH-----RNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY---YRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLT-HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYRH
[Model]
3mtr: CRYSTAL STRUCTURE OF THE IG5-FN1 TANDEM OF HUMAN NCAM Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
339-426
3mtrB
21%
>target
----------------------------------------------------------------------------------------------TQPPSRPIKLVANAITATSTRLSWNEPSSLGGRPEIWYEVKCSGRGECGT-VVMTPGDKKLSTRSVQINGLRPSSDYTFLVFAKNKVSA---------------
>3mtrB
MYAPKLQGPVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCTAVNRIGQESLEFILVQADTPSSPSIDQVE-PYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVQ
[Model]
339-442
3mtrA
21%
>target
------------------------------------------------------------------------------------------------TQPPSRPIKLVANAITATSTRLSWNEPSSLGGRPEIWYEVKCSGRGECGT-VVMTPGDKKLSTRSVQINGLRPSSDYTFLVFAKNKVSAQFPEFSEKNAVIDIRT--
>3mtrA
SHMYAPKLQGPVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCTAVNRIGQESLEFILVQADTPSSPSIDQVE-PYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGL-----GEISAASEFKTQP
[Model]
401-533
3mtrA
11%
>target
-------------------------------------------------------------RSVQINGLRPSSDYTFLVFAKNKVSAQFPEFSEKNAVIDIRTRSEEEDVPPVSHLRVDASQSDGITIAWSVSD----SDVSDFEVEVRPAIVKKRT--FETR--HVNMTYTTFIGLNPETVYQFRVRIRDDLRWSQPISYQ------
>3mtrA
SHMYAPKLQGPVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCTAVNRIGQES-----LEFILV---QADTPSSPSI--DQV-EPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQP
[Model]
401-533
3mtrB
11%
>target
-----------------------------------------------------------RSVQINGLRPSSDYTFLVFAKNKVSAQFPEFSEKNAVIDIRTRSEEEDVPPVSHLRVDASQSDGITIAWSVSD----SDVSDFEVEVRPAIVKKRTF--ETR--HVNMTYTTFIGLNPETVYQFRVRIRDDLRWSQPISYQ--------
>3mtrB
MYAPKLQGPVAVYTWEGNQVNITCEVFAYPSATISWFRDGQLLPSSNYSNIKIYNTPSASYLEVTPDSENDFGNYNCTAVNRIGQES-----LEFILVQ---ADTPSSPSI--DQV-EPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVQ
[Model]
2e3v: CRYSTAL STRUCTURE OF THE FIRST FIBRONECTIN TYPE III DOMAINOF NEURAL CELL ADHESION MOLECULE SPLICING ISOFORM FROM HUMAN MUSCLE CULTURE LAMBDA-4.4 Solved by: X-RAY, Resolution: 1.95A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
341-442
2e3vA
19%
>target
-PPSRPIKLVANAITATSTRLSWNEPSSLGGRPEIWYEVKCSGRGECGTVVM-TPGDKKLSTRSVQINGLRPSSDYTFLVFAKNKVSAQFPEFSEKNAVIDIRT-------
>2e3vA
SGPSSPSIDQVE-PYSSTAQVQFDEP-E-ATVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGL-----GEISAASEFKTQPVREPS
[Model]
446-536
2e3vA
13%
>target
-EEDVPPVSHLRVDASQSDGITIAWSVSD--SDVSDFEVEVRPAIVKKRTFET--R--HVNMTYTTFIGLNPETVYQFRVRIRDDLRWSQPISYQLGR--------
>2e3vA
SGPSSPSIDQ--V-EPYSSTAQVQFDEPEATVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPVREPS
[Model]
341-442
2e3vB
19%
>target
-PPSRPIKLVANAITATSTRLSWNEPSSLGGRPEIWYEVKCSGRGECGT-VVMTPGDKKLSTRSVQINGLRPSSDYTFLVFAKNKVSAQFPEFSEKNAVIDIRT---
>2e3vB
SGPSSPSIDQV-EPYSSTAQVQFDEPEV----PILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGL-----GEISAASEFKTQPV
[Model]
446-533
2e3vB
14%
>target
-EEDVPPVSHLRVDASQSDGITIAWSVSDSDVSDFEVEVRPAIVKKRT--FETR--HVNMTYTTFIGLNPETVYQFRVRIRDDLRWSQPISYQ-------
>2e3vB
SGPSSPSID--QV-EPYSSTAQVQFDEPEVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPV
[Model]
340-425
2e3vC
22%
>target
QPPSRPIKLVANAITATSTRLSWNEPSSLGGRPEIWYEVKCSGRGECGTVVM-TPGDKKLSTRSVQINGLRPSSDYTFLVFAKNKVS---------------
>2e3vC
SGPSSPSIDQ-VEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPV
[Model]
446-534
2e3vC
12%
>target
-EEDVPPVSHLRVDASQSDGITIAWSVSD----SDVSDFEVEVRPAIVKKRTFE--T--RHVNMTYTTFIGLNPETVYQFRVRIRDDLRWSQPISYQL------
>2e3vC
SGPSSPSID---QVEPYSSTAQVQFDEPEATGGVPILKYKAEWRAVGEEVWHSKWYDAKEASMEGIVTIVGLKPETTYAVRLAALNGKGLGEISAASEFKTQPV
[Model]
3n9x: CRYSTAL STRUCTURE OF MAP KINASE FROM PLASMODIUM BERGHEI, P Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
689-990
3n9xA
18%
>target
--------------PNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA-----EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAIT-HRKFTPSSDVWSFGVVIWEVCSFGERPYWDWT------------------NQKVISEVMI------------------------G-YRLPPP-----MDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------------------------------------------------------
>3n9xA
RENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTE---------------------------KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESGIIH-----RDLKPANCLLNQDCSVKVCDFGLARTIH---------------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN-MLQSHINDPTNRFPLFPGSSCFPHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKKKLETKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNFYNNE
[Model]
689-990
3n9xB
18%
>target
---------------PNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA-----EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAIT-HRKFTPSSDVWSFGVVIWEVCSFGERPYWDWT-----------------NQKVISEVMI---------------G---------YRLPPP-----MDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------------------------------------------------------
>3n9xB
GRENLYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEK---------------------------NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHESGIIH-----RDLKPANCLLNQDCSVKVCDFGLARTINS-------H------VVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN-MLQSHINDPTNRFPLFPGSSCFHEKSNRDQLNIIFNIIGTPTEDDLKNIKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALD--HPYLKDVRKKKLETKKIILPFDDWMVLSETQLRYIFLKEVQSFHPELVIPSVFTIHENNFYNN
[Model]
4f9c: HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND XL413 Solved by: X-RAY, Resolution: 2.08A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
4f9cA
17%
>target
---------------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQF-SHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDME-LRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDW-TNQKVISEVMIGY--------------------RLPP-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>4f9cA
KKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQV------------------------GPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVH-----RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELL----KFVRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM
[Model]
4f99: HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE Solved by: X-RAY, Resolution: 2.33A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
4f99A
17%
>target
---------------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQF-SHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDME-LRCKIADFGLSRGVRSEGSSVEPEY--TTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWT-NQKVISEVMIGY--------------------RLPP-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>4f99A
KKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQV------------------------GPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVH-----RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM
[Model]
4f9b: HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND PHA767491 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
4f9bA
17%
>target
-----------------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQF-SHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDME-LRCKIADFGLSRGVRSEGSSVEPEYT-----TNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDW-TNQKVISEVMIGY--------------------RLP------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>4f9bA
GVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQV------------------------GPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVH-----RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM
[Model]
690-990
4f9bC
17%
>target
-------------------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQF-SHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDME-LRCKIADFGLSRGVRSEGSSVEPEYT-TNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWT-NQKVISEVMIGY--------------------RL------------PPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>4f9bC
LAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQV------------------------GPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVH-----RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM
[Model]
4f9a: HUMAN CDC7 KINASE IN COMPLEX WITH DBF4 AND NUCLEOTIDE Solved by: X-RAY, Resolution: 2.17A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
4f9aA
17%
>target
-----------------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQF-SHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDME-LRCKIADFGLSRGVRSEGSSVEPEYT--TNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTN-QKVISEVMIG--------------------YRLP------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>4f9aA
GVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQV------------------------GPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS-------LSFQEVREYMLNLFKALKRIHQFGIVH-----RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM
[Model]
690-990
4f9aC
17%
>target
-------------------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQF-SHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDME-LRCKIADFGLSRGVRSEGSSVEPEYT--TNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDW-TNQKVISEVMIG--------------------YRLP------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-
>4f9aC
LAGVKKDIEKLYEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQV------------------------GPEEKIALKHLIPTS---HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVH-----RDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS-GRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGWNEVPDEAYDLLDKLLDLNPASRITAEEALL--HPFFKDM
[Model]
3e3p: GLYCOGEN SYNTHASE KINASE FROM LEISHMANIA MAJOR Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
743-990
3e3pB
17%
>target
---------------------------ETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAE-------PVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLT--DMGYVHRVSFLRDLAARNVLLD-MELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIG------------------YRLP-------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------------------------------------
>3e3pB
AAADERSRKEMDRFQVTVQLGKEKSTGMSVAIKKVIQDP--RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH-----RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-----VAY--ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV
[Model]
743-990
3e3pA
17%
>target
---------------------------ETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAE-------PVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLT--DMGYVHRVSFLRDLAARNVLLD-MELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGY------------------RLP-------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------------------------------------
>3e3pA
AAADERSRKEMDRFQVEVQLGKEKSTGMSVAIKKVIQD--PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCH-----RDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-----VAY--ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMML-GEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC--HPYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLV
[Model]
3nie: CRYSTAL STRUCTURE OF PF11_0147 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
689-990
3nieA
16%
>target
-------------PNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA-----EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAIT-HRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTN------------------QKVISEVMIGYR-------------------------LPP-----PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------------------------------------------------
>3nieA
LYFQGAIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNANK---------------------------NVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIAD-SDLKKLFKTP----IFLTEQHVKTILYNLLLGEKFIHESGIIH-----RDLKPANCLLNQDCSVKICDFGLARTINTS------H------VVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN-MMKSHINNPTNRFPLFPGSSCFPHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALS--HPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRYIFLKEIQSFHADLIIPAKLN
[Model]
690-990
3nieB
16%
>target
---------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKS-GSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSA-----EPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAIT-HRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTN------------------QKVISEVMI-------------------------GYRLP---PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------------------------------------------------------
>3nieB
AIIKNVKVPDNYEIKHLIGRGSYGYVYLAYDKNAN---------------------------KNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEIA-DSDLKKLFKTPI----FLTEQHVKTILYNLLLGEKFIHESGIIH-----RDLKPANCLLNQDCSVKICDFGLARTITS-------H------VVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLN-MMKSHINNPTNRFPLFPGSSCFPHEKSNRDQLNIIFNVIGTPPEEDLKTKQEVIKYIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALS--HPYLKDVRKENLENFSTEKIILPFDDWMVLSETQLRYIFLKEIQSFHADLIIPAKLNIHQKSF
[Model]
4bbm: CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN WITH BOUND TCS 2312 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
696-990
4bbmA
17%
>target
------------QVIGG-GEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIG--Y------------------RL-------PP---PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------------------
>4bbmA
TENLYFQSMEKYENLGLVGSYGMVMKCRNKDTG---------------------------RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHNIIH-----RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD----DE--VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQMDGFAERFSQELQLKVQKDA
[Model]
694-990
4bbmB
16%
>target
----ITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP------------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------------------
>4bbmB
YFQSMEKYENLGSYGMVMKCRNKDTG---------------------------RIVAIKKFK--------KIAMREIKLLKQLRHENLVNLLEV------CYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHNIIH-----RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD------EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQMDGFAERFSQELQLKVQKDA
[Model]
4aaa: CRYSTAL STRUCTURE OF THE HUMAN CDKL2 KINASE DOMAIN Solved by: X-RAY, Resolution: 1.53A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
4aaaA
16%
>target
------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIG--------------------YRLP----------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------------
>4aaaA
LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTG---------------------------RIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSHNIIH-----RDIKPENILVSQSGVVKLCDFGFAEV------------------ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFM-GEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH--HDFFQMDGFAERFSQELQL
[Model]
1oiu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1oiuA
15%
>target
----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>1oiuA
PGSMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
691-990
1oiuC
16%
>target
---DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oiuC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL---GVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1ogu: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 2-ARYLAMINO-4-CYCLOHEXYLMETHYL-5-NITROSO-6- AMINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1oguA
15%
>target
----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>1oguA
PGSMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
690-990
1oguC
16%
>target
----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGY-RL-PPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oguC
PGSMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1h25: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM RETINOBLASTOMA-ASSOCIATED PROTEIN Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h25A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-----
>1h25A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPV
[Model]
691-990
1h25C
16%
>target
---DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKS-GSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-----
>1h25C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPV
[Model]
3le6: THE STRUCTURE OF CYCLIN DEPENDENT KINASE 2 (CKD2) WITH A PYRAZOLOBENZODIAZEPINE INHIBITOR Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3le6A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ------
>3le6A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIP--------STAIREISLLKELNHPNIVKLLDVIH--TKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVP
[Model]
2c4g: STRUCTURE OF CDK2-CYCLIN A WITH PHA-533514 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
689-990
2c4gA
15%
>target
----PNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>2c4gA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
688-990
2c4gC
15%
>target
-SPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2c4gC
VDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qwk: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-150 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qwkA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qwkA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1h00: CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
692-990
1h00A
15%
>target
---VFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1h00A
MENFQKVEKI--GEYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAE----------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2vtl: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2vtlA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2vtlA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3py0: CDK2 IN COMPLEX WITH INHIBITOR SU9516 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3py0A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3py0A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r8u: CDK2 IN COMPLEX WITH INHIBITOR RC-1-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r8uA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r8uA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qru: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC1-12 Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qruA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qruA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3ral: CDK2 IN COMPLEX WITH INHIBITOR RC-2-34 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3ralA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3ralA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAV-------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3s00: CDK2 IN COMPLEX WITH INHIBITOR L4-14 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3s00A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3s00A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2r3i: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3iA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3iA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2c6k: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2c6kA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2c6kA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1wcc: SCREENING FOR FRAGMENT BINDING BY X-RAY CRYSTALLOGRAPHY Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1wccA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1wccA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3tiz: CDK2 IN COMPLEX WITH NSC 111848 Solved by: X-RAY, Resolution: 2.02A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-991
3tizA
15%
>target
-DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQP---------
>3tizA
ENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1aq1: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR STAUROSPORINE Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1aq1A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1aq1A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLEV-------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2wma: STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OLIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2wmaA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2wmaA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
2wmaC
16%
>target
---DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2wmaC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL---GVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2b52: HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DPH-042562 Solved by: X-RAY, Resolution: 1.88A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2b52A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGY-----------------R--LP---------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2b52A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAHEV-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rmf: CDK2 IN COMPLEX WITH INHIBITOR RC-2-33 Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3rmfA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rmfA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRL------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAV-------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1b38: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1b38A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1b38A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r7e: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-67 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r7eA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r7eA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1gij: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1gijA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1gijA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIR----------AIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLKTFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAV--------------------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1vyw: STRUCTURE OF CDK2/CYCLIN A WITH PNU-292137 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
688-990
1vywA
15%
>target
---SPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1vywA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
1vywC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1vywC
DMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1h0w: HUMAN CYCLIN DEPENDENT PROTEIN KINASE 2 IN COMPLEX WITH THINHIBITOR 2-AMINO-6-[CYCLOHEX-3-ENYL]METHOXYPURINE Solved by: X-RAY, Resolution: 2.10A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h0wA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1h0wA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGV--------------PVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qzf: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-52 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qzfA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qzfA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qtr: CDK2 IN COMPLEX WITH INHIBITOR RC-1-148 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qtrA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qtrA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFG--------------VVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1urw: CDK2 IN COMPLEX WITH AN IMIDAZO[1,2-B]PYRIDAZINE Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
692-990
1urwA
15%
>target
---VFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1urwA
MENFQKVEKI--GEYGVVYKARNKLTGE---------------------------VVALKKITA----------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAV-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rni: CDK2 IN COMPLEX WITH INHIBITOR RC-3-86 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rniA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rniA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rk9: CDK2 IN COMPLEX WITH INHIBITOR RC-2-74 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rk9A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rk9A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r1y: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-134 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r1yA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r1yA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1sgg: THE SOLUTION STRUCTURE OF SAM DOMAIN FROM THE RECEPTOR TYROSINE KINASE EPHB2, NMR, 10 STRUCTURES Solved by: NMR, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1031-1082
1sggA
15%
>target
--PMPSLDDFLRQIGLNHVYGQLVSNNIHSVSDLANTSHLDLLAYGLMSAECST-------------
>1sggA
YTSFNTVDEWLDAIKMSQYKESFASAGFTTFDIVSQMTVEDILRVGVTLAGHQKKILNSIQVMRAQM
[Model]
3pxf: CDK2 IN COMPLEX WITH TWO MOLECULES OF 8-ANILINO-1-NAPHTHALSULFONATE Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3pxfA
15%
>target
-----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3pxfA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1jvp: CRYSTAL STRUCTURE OF HUMAN CDK2 (UNPHOSPHORYLATED) IN COMPLEX WITH PKF049-365 Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1jvpP
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1jvpP
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF----------V------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3s2p: CRYSTAL STRUCTURE OF CDK2 WITH A 2-AMINOPYRIMIDINE COMPOUN Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3s2pA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3s2pA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2wih: STRUCTURE OF CDK2-CYCLIN A WITH PHA-848125 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
688-990
2wihA
15%
>target
---SPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2wihA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
2wihC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2wihC
DMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r9d: CDK2 IN COMPLEX WITH INHIBITOR RC-2-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r9dA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r9dA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3sw4: CRYSTAL STRUCTURE OF THE CDK2 IN COMPLEX WITH THIAZOLYLPYRINHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3sw4A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRL-------------------P---------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3sw4A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIP--------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF----------------GVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2v0d: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2v0dA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2v0dA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rk5: CDK2 IN COMPLEX WITH INHIBITOR RC-2-72 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rk5A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rk5A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2a4l: HUMAN CYCLIN-DEPENDENT KINASE 2 IN COMPLEX WITH ROSCOVITIN Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2a4lA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2a4lA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIA-----------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1jst: PHOSPHORYLATED CYCLIN-DEPENDENT KINASE-2 BOUND TO CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1jstA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1jstA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
691-990
1jstC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1jstC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3eid: CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR Solved by: X-RAY, Resolution: 3.15A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3eidA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>3eidA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYT------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
691-990
3eidC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>3eidC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRL---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--Y------THVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2j9m: CRYSTAL STRUCTURE OF CDK2 IN COMPLEX WITH MACROCYCLIC AMINOPYRIMIDINE Solved by: X-RAY, Resolution: 2.5A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2j9mA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2j9mA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLV---------------------TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1pxo: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2-AMINO-4-METHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(3-NITRO-PHENYL)-AMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1pxoA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1pxoA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1fq1: CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) ICOMPLEX WITH PHOSPHO-CDK2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1fq1B
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1fq1B
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3qx2: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-190 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qx2A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qx2A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2r3p: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3pA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3pA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1oiy: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1oiyA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oiyA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1oiyC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oiyC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2r3f: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3fA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3fA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2w17: CDK2 IN COMPLEX WITH THE IMIDAZOLE PYRIMIDINE AMIDE, COMPOUND (S)-8B Solved by: X-RAY, Resolution: 2.15A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2w17A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2w17A
MENFQKVEKIGET-YGVVYKARNKLTG---------------------------EVVALKKIRL----DVPSTAIREISLLKELNHPNIVKLLDVIHT-EKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAV-------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1ke9: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[4- ({[AMINO(IMINO)METHYL]AMINOSULFONYL)ANILINO]METHYLENE}-2-OXO-2,3-DIHYDRO-1H-INDOLE Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1ke9A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1ke9A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF----------V------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r9o: CDK2 IN COMPLEX WITH INHIBITOR RC-2-143 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r9oA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r9oA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFG--------------VVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1ol1: CYCLIN A BINDING GROOVE INHIBITOR H-CIT-CIT-LEU-ILE-(P-F- PHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1ol1A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1ol1A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
1ol1C
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1ol1C
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3qxo: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-84 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qxoA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qxoA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1h28: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P107 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h28A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h28A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1h28C
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h28C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3qtq: CDK2 IN COMPLEX WITH INHIBITOR RC-1-137 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qtqA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qtqA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2iw6: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A COMPLEXED WITH A BISANILINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2iw6A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------
>2iw6A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPH
[Model]
690-990
2iw6C
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------
>2iw6C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKTFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPH
[Model]
3rm6: CDK2 IN COMPLEX WITH INHIBITOR KVR-2-80 Solved by: X-RAY, Resolution: 1.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rm6A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rm6A
MENFQKVEKIGEGT-GVVYKARNKLTG---------------------------EVVALKKIRT---EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2bkz: STRUCTURE OF CDK2-CYCLIN A WITH PHA-404611 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
688-990
2bkzA
15%
>target
---SPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2bkzA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
2bkzC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>2bkzC
DMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
1ol2: CYCLIN A BINDING GROOVE INHIBITOR H-ARG-ARG-LEU-ASN-(P-F- PHE)-NH2 Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1ol2A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1ol2A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
1ol2C
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1ol2C
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1p5e: THE STRUCURE OF PHOSPHO-CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR 4,5,6,7-TETRABROMOBENZOTRIAZOLE (TBS) Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1p5eA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1p5eA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1p5eC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1p5eC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2r3j: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3jA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3jA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAREV-----------------VTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2r64: CRYSTAL STRUCTURE OF A 3-AMINOINDAZOLE COMPOUND WITH CDK2 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2r64A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r64A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3ql8: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-260 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3ql8A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3ql8A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rjc: CDK2 IN COMPLEX WITH INHIBITOR L4-12 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rjcA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rjcA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r8v: CDK2 IN COMPLEX WITH INHIBITOR RC-1-135 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r8vA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r8vA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qtu: CDK2 IN COMPLEX WITH INHIBITOR RC-2-132 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qtuA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qtuA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2vv9: CDK2 IN COMPLEX WITH AN IMIDAZOLE PIPERAZINE Solved by: X-RAY, Resolution: 1.9A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2vv9A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP-----------------P-----------MDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2vv9A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRL-----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAV-------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1buh: CRYSTAL STRUCTURE OF THE HUMAN CDK2 KINASE COMPLEX WITH CELL CYCLE-REGULATORY PROTEIN CKSHS1 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1buhA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYR-----------------L--P---------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ------
>1buhA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLD------TTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVP
[Model]
3r28: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-140 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r28A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r28A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1pxi: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,5-DICHLORO-THIOPHEN-3-YL)-PYRIMIDIN-2- YLAMINE Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1pxiA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1pxiA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3bht: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 3 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3bhtA
15%
>target
---NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3bhtA
GSMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLD-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
3bhtC
16%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGY--RLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>3bhtC
SMENFQKVEKIGEGTYGVVYKARNKLTGE---------------------------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3igg: NOVEL CDK-5 INHIBITORS - CRYSTAL STRUCTURE OF INHIBITOR EFWITH CDK-2 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3iggA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3iggA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2wpa: OPTIMISATION OF 6,6-DIMETHYL PYRROLO 3,4-C PYRAZOLES: IDENTIFICATION OF PHA-793887, A POTENT CDK INHIBITOR SUITABLE FOR INTRAVENOUS DOSING Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
688-990
2wpaA
15%
>target
---SPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2wpaA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
2wpaC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2wpaC
DMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1fvv: THE STRUCTURE OF CDK2/CYCLIN A IN COMPLEX WITH AN OXINDOLEINHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1fvvA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1fvvA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
691-990
1fvvC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1fvvC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1f0m: MONOMERIC STRUCTURE OF THE HUMAN EPHB2 SAM (STERILE ALPHA MOTIF) DOMAIN Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
1031-1082
1f0mA
15%
>target
--PMPSLDDFLRQIGLNHVYGQLVSNNIHSVSDLANTSHLDLLAYGLMSAECST-----------------
>1f0mA
YTSFNTVDEWLEAIKMGQYKESFANAGFTSFDVVSQMMMEDILRVGVTLAGHQKKILNSIQVMRAQMNQIQ
[Model]
2r3m: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3mA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3mA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAREV-----------------VTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2cjm: MECHANISM OF CDK INHIBITION BY ACTIVE SITE PHOSPHORYLATIONCDK2 Y15P T160P IN COMPLEX WITH CYCLIN A STRUCTURE Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2cjmA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----
>2cjmA
MENFQKVEKIGEGT-GVVYKARNKLTG---------------------------EVVALKKIREG----VPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKP
[Model]
691-990
2cjmC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKS-GSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2cjmC
MENFQKVEKIGEGT-GVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2b53: HUMAN CYCLIN DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH DIN-234325 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2b53A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2b53A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2wmb: STRUCTURAL AND THERMODYNAMIC CONSEQUENCES OF CYCLIZATION OLIGANDS FOR THE RECRUITMENT SITE OF CYCLIN A Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2wmbA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2wmbA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
2wmbC
16%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2wmbC
SMENFQKVEKIGEGTYGVVYKARNKLTGE---------------------------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL--KVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3rm7: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-91 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rm7A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rm7A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qzg: CDK2 IN COMPLEX WITH INHIBITOR JWS-6-76 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qzgA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qzgA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rpr: CDK2 IN COMPLEX WITH INHIBITOR RC-2-49 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rprA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rprA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFG--------------VVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qqj: CDK2 IN COMPLEX WITH INHIBITOR L2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qqjA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qqjA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3lfq: CRYSTAL STRUCTURE OF CDK2 WITH SAR60, AN AMINOINDAZOLE TYPINHIBITOR Solved by: X-RAY, Resolution: 2.03A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3lfqA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3lfqA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIR--------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1qmz: PHOSPHORYLATED CDK2-CYCLYIN A-SUBSTRATE PEPTIDE COMPLEX Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1qmzA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1qmzA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1qmzC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1qmzC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1vyz: STRUCTURE OF CDK2 COMPLEXED WITH PNU-181227 Solved by: X-RAY, Resolution: 2.21A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1vyzA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1vyzA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKITA----------IREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGE--------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2ds1: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2ds1A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2ds1A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLKTFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3rkb: CDK2 IN COMPLEX WITH INHIBITOR RC-2-73 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3rkbA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3rkbA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1ckp: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR PURVALANOL B Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1ckpA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1ckpA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2cci: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 CYCLIN A IN COMPLEX WITHA PEPTIDE CONTAINING BOTH THE SUBSTRATE AND RECRUITMENT SITES OF CDC6 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2cciA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2cciA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
2cciC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2cciC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1pxk: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)PYRIMIDIN-2-YL]N'-HYDROXYIMINOFORMAMIDE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1pxkA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1pxkA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2c6l: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-991
2c6lA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQP---------
>2c6lA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH------EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1e1v: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR NU2058 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1e1vA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1e1vA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2uzb: CRYSTAL STRUCTURE OF HUMAN CDK2 COMPLEXED WITH A THIAZOLIDINONE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2uzbA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2uzbA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
2uzbC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2uzbC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3s0o: CDK2 IN COMPLEX WITH INHIBITOR RC-1-138 Solved by: X-RAY, Resolution: 2.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3s0oA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3s0oA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFARAFGVPVRTY------T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2c69: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2c69A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2c69A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
4ez3: CDK2 IN COMPLEX WITH NSC 134199 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
4ez3A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>4ez3A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2c5x: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2c5xA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2c5xA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
2c5xC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2c5xC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3ddp: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR CR8 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3ddpC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3ddpC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
3ddpA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>3ddpA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
3fz1: CRYSTAL STRUCTURE OF A BENZTHIOPHENE INHIBITOR BOUND TO HUMAN CYCLIN-DEPENDENT KINASE-2 (CDK-2) Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-991
3fz1A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQP---------
>3fz1A
MENFQKVEKIGEGTYGVVYKARNKLTGE---------------------------VVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGHE-------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1h24: CDK2/CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT PEPTIDE FROM E2F Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h24A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-----
>1h24A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPV
[Model]
690-990
1h24C
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSS-AKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-----
>1h24C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPV
[Model]
2wip: STRUCTURE OF CDK2-CYCLIN A COMPLEXED WITH 8-ANILINO-1- METHYL-4,5-DIHYDRO-1H-PYRAZOLO[4,3-H] QUINAZOLINE-3- CARBOXYLIC ACID Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
701-990
2wipA
15%
>target
-----------GEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2wipA
PLVDMENFQKVEKIGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
697-990
2wipC
14%
>target
------VIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKS-GSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2wipC
DMENFQKVEK--IGVVYKARNKLTGE---------------------------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1h1q: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH THE INHIBITOR NU6094 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h1qA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h1qA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1h1qC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h1qC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
4acm: CDK2 IN COMPLEX WITH 3-AMINO-6-(4-{[2-(DIMETHYLAMINO)ETHYLSULFAMOYL}-PHENYL)-N-PYRIDIN-3-YLPYRAZINE-2-CARBOXAMIDE Solved by: X-RAY, Resolution: 1.63A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-991
4acmA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQP---------
>4acmA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIH--TKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARV------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qqh: CDK2 IN COMPLEX WITH INHIBITOR L2-2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qqhA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qqhA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
4gcj: CDK2 IN COMPLEX WITH INHIBITOR RC-3-89 Solved by: X-RAY, Resolution: 1.42A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
4gcjA
15%
>target
-------NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>4gcjA
LGSPEFMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2c6m: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2c6mA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2c6mA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLV-----PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2jgz: CRYSTAL STRUCTURE OF PHOSPHO-CDK2 IN COMPLEX WITH CYCLIN B Solved by: X-RAY, Resolution: 2.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-989
2jgzA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYIL-
>2jgzA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQD
[Model]
2c6t: CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2c6tA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2c6tA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
2c6tC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2c6tC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1e9h: THR 160 PHOSPHORYLATED CDK2-HUMAN CYCLIN A3 COMPLEX WITH THE INHIBITOR INDIRUBIN-5-SULPHONATE BOUND Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1e9hA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1e9hA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1e9hC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1e9hC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3r9n: CDK2 IN COMPLEX WITH INHIBITOR RC-2-21 Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r9nA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r9nA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFG--------------VVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2r3h: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3hA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3hA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIP--------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2fvd: CYCLIN DEPENDENT KINASE 2 (CDK2) WITH DIAMINOPYRIMIDINE INHIBITOR Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2fvdA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2fvdA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIR-----------LREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLAFGVPVRTYT------H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3dog: STRUCTURE OF THR 160 PHOSPHORYLATED CDK2/CYCLIN A IN COMPLEX WITH THE INHIBITOR N-&-N1 Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3dogC
16%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>3dogC
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL--GTVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
690-990
3dogA
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3dogA
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1pxj: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YLAMI Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1pxjA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1pxjA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3unj: CDK2 IN COMPLEX WITH INHIBITOR YL1-038-31 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3unjA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3unjA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2whb: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2whbA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2whbA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
691-990
2whbC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2whbC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3r9h: CDK2 IN COMPLEX WITH INHIBITOR RC-2-142 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r9hA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r9hA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1ykr: CRYSTAL STRUCTURE OF CDK2 WITH AN AMINOIMIDAZO PYRIDINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1ykrA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1ykrA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2vth: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.0A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2vthA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2vthA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIR--------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF-----------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3ezv: CDK-2 WITH INDAZOLE INHIBITOR 9 BOUND AT ITS ACTIVE SITE Solved by: X-RAY, Resolution: 1.99A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3ezvA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3ezvA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLV--------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1v1k: CDK2 IN COMPLEX WITH A DISUBSTITUTED 4, 6-BIS ANILINO PYRIMIDINE CDK4 INHIBITOR Solved by: X-RAY, Resolution: 2.31A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1v1kA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1v1kA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIR--------LTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARV------------------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qrt: CDK2 IN COMPLEX WITH INHIBITOR NSK-MC2-55 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qrtA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qrtA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1hck: HUMAN CYCLIN-DEPENDENT KINASE 2 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1hckA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1hckA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1gz8: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR 2-AMINO-6-(3'-METHYL-2'-OXO)BUTOXYPURINE Solved by: X-RAY, Resolution: 2.05A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1gz8A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1gz8A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3pxq: CDK2 IN COMPLEX WITH 3 MOLECULES OF 8-ANILINO-1-NAPHTHALEN Solved by: X-RAY, Resolution: 1.90A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3pxqA
15%
>target
-----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3pxqA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----THE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2bpm: STRUCTURE OF CDK2-CYCLIN A WITH PHA-630529 Solved by: X-RAY, Resolution: 2.60A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
688-990
2bpmA
15%
>target
---SPNDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2bpmA
PLVDMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
2bpmC
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2bpmC
DMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2r3o: CRYSTAL STRUCTURE OF CYCLIN-DEPENDENT KINASE 2 WITH INHIBITOR Solved by: X-RAY, Resolution: 1.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2r3oA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2r3oA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2vtr: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
2vtrA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2vtrA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1w98: THE STRUCTURAL BASIS OF CDK2 ACTIVATION BY CYCLIN E Solved by: X-RAY, Resolution: 2.70A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1w98A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>1w98A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
1pf8: CRYSTAL STRUCTURE OF HUMAN CYCLIN-DEPENDENT KINASE 2 COMPLEXED WITH A NUCLEOSIDE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1pf8A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1pf8A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3eoc: CDK2/CYCLINA COMPLEXED WITH A IMIDAZO TRIAZIN-2-AMINE Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3eocA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3eocA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
3eocC
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>3eocC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3tiy: CDK2 IN COMPLEX WITH NSC 35676 Solved by: X-RAY, Resolution: 2.02A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-991
3tiyA
15%
>target
-DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQP---------
>3tiyA
ENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2wev: TRUNCATION AND OPTIMISATION OF PEPTIDE INHIBITORS OF CDK2,CYCLIN A THROUGH STRUCTURE GUIDED DESIGN Solved by: X-RAY, Resolution: 3.00A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2wevA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ-------
>2wevA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPH
[Model]
691-990
2wevC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2wevC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3qu0: CDK2 IN COMPLEX WITH INHIBITOR RC-2-38 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qu0A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qu0A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2vu3: IDENTIFICATION OF N-(4-PIPERIDINYL)-4-(2,6- DICHLOROBENZOYLAMINO)-1H-PYRAZOLE-3-CARBOXAMIDE (AT7519),A NOVEL CYCLIN DEPENDENT KINASE INHIBITOR USING FRAGMENT-BASED X-RAY CRYSTALLOGRAPHY AND STRUCTURE BASED DRUG DESIGN. Solved by: X-RAY, Resolution: 1.85A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2vu3A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2vu3A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIR--------LTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGFGVPVRTYTH----------EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3pxz: CDK2 TERNARY COMPLEX WITH JWS648 AND ANS Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3pxzA
15%
>target
-----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3pxzA
SPEFMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3bhu: STRUCTURE OF PHOSPHORYLATED THR160 CDK2/CYCLIN A IN COMPLEWITH THE INHIBITOR MERIOLIN 5 Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3bhuA
15%
>target
---NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3bhuA
GSMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLD-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
3bhuC
15%
>target
---NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIG-YRL-PPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>3bhuC
GSMENFQKVEKIGEGTYGVVYKARNKLTGE---------------------------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3f5x: CDK-2-CYCLIN COMPLEX WITH INDAZOLE INHIBITOR 9 BOUND AT ITACTIVE SITE Solved by: X-RAY, Resolution: 2.40A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3f5xA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3f5xA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDP-KRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
691-990
3f5xC
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3f5xC
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1h27: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P27 Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h27A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h27A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1h27C
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKS-GSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRL-----------------------PPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h27C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
3qql: CDK2 IN COMPLEX WITH INHIBITOR L3 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qqlA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qqlA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qtx: CDK2 IN COMPLEX WITH INHIBITOR RC-2-35 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qtxA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qtxA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1oir: IMIDAZOPYRIDINES: A POTENT AND SELECTIVE CLASS OF CYCLIN- DEPENDENT KINASE INHIBITORS IDENTIFIED THROUGH STRUCTURE-BASED HYBRIDISATION Solved by: X-RAY, Resolution: 1.91A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1oirA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oirA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKIRL---------TAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2c5y: DIFFERENTIAL BINDING OF INHIBITORS TO ACTIVE AND INACTIVE CDK2 PROVIDES INSIGHTS FOR DRUG DESIGN Solved by: X-RAY, Resolution: 2.25A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2c5yA
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>2c5yA
MENFQKVEKIGEGTYGVVYKARNKLTGE---------------------------VVALKKIGV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
3ej1: CDK2/CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR Solved by: X-RAY, Resolution: 3.22A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3ej1A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3ej1A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
690-990
3ej1C
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>3ej1C
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLT--EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
3py1: CDK2 TERNARY COMPLEX WITH SU9516 AND ANS Solved by: X-RAY, Resolution: 2.49A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
3py1A
15%
>target
-----NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3py1A
SPEFMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT------HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3qtz: CDK2 IN COMPLEX WITH INHIBITOR RC-2-36 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3qtzA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3qtzA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
2iw8: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2-CYCLIN A F82H-L83V-H84D MUTANT WITH AN O6-CYCLOHEXYLMETHYLGUANINE INHIBITOR Solved by: X-RAY, Resolution: 2.30A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2iw8A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ---------
>2iw8A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASA--LTGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLR
[Model]
690-990
2iw8C
17%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHRK-FTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>2iw8C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTL---GVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1pxl: HUMAN CYCLIN DEPENDENT KINASE 2 COMPLEXED WITH THE INHIBITOR [4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-(4-TRIFLUOROMETHYL-PHENYL)-AMINE Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
1pxlA
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1pxlA
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIVP-------STAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----H--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1ke7: CYCLIN-DEPENDENT KINASE 2 (CDK2) COMPLEXED WITH 3-{[(2,2- DIOXIDO-1,3-DIHYDRO-2-BENZOTHIEN-5-YL)AMINO]METHYLENE}-5-(1,3-OXAZOL-5-YL)-1,3-DIHYDRO-2H-INDOL-2-ONE Solved by: X-RAY, Resolution: 2.20A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1ke7A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>1ke7A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAF----------V------VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
1oi9: STRUCTURE OF HUMAN THR160-PHOSPHO CDK2/CYCLIN A COMPLEXED WITH A 6-CYCLOHEXYLMETHYLOXY-2-ANILINO-PURINE INHIBITOR Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1oi9A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oi9A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----T--HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1oi9C
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1oi9C
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
1h26: CDK2/CYCLIN A IN COMPLEX WITH AN 11-RESIDUE RECRUITMENT PEPTIDE FROM P53 Solved by: X-RAY, Resolution: 2.80A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
1h26A
15%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGS-SAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP----------------------------PPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h26A
SMENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY------THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
690-990
1h26C
16%
>target
--NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSG-SSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPPPMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ--------
>1h26C
SMENFQKVEKIGEGTYGVVYKARNKLTGE---------------------------VVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY----TH--EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLG-TVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHL
[Model]
2w06: STRUCTURE OF CDK2 IN COMPLEX WITH AN IMIDAZOLYL PYRIMIDINECOMPOUND 5C Solved by: X-RAY, Resolution: 2.04A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
690-990
2w06A
15%
>target
-NDVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITHR-KFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLPP----------------------------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>2w06A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRV------PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFE---------------VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r71: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-162 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]
691-990
3r71A
15%
>target
--DVFITQVIGGGEFGDVCLGGLSKNSPAAAKWSVSNTTMGRGGGGGGYESEPYETVAIKTLKSGSSAKAKAEFLTEATIMGQFSHPNVIRLIGVVTSAEPVMIVAEYMANGSLDQFLRNTDQRGEKVHWEKITEMLYGIASGMKYLTDMGYVHRVSFLRDLAARNVLLDMELRCKIADFGLSRGVRSEGSSVEPEYTTNGGKIPVRWTAPEAITH-RKFTPSSDVWSFGVVIWEVCSFGERPYWDWTNQKVISEVMIGYRLP-----------------P-----------PMDCPMGLYRIAQWCWKMERHERPTFTQLLATFHKYILQ----------
>3r71A
MENFQKVEKIGEGTYGVVYKARNKLTG---------------------------EVVALKKIRTE---GVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASAL--TGIPLPLIKSYLFQLLQGLAFCHSHRVLH-----RDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT----HE--VVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA--HPFFQDVTKPVPHLRL
[Model]
3r6x: CDK2 IN COMPLEX WITH INHIBITOR KVR-1-158 Solved by: X-RAY, Resolution: 2.50A, Identified by HHSEARCH
[ SMTL ]
[ RCSB ]
[ PDBe ]
[ SCOP ]
[ CATH ]